Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange
dc.contributor.author | Levy, Carol J. | |
dc.contributor.author | Foster, Nicole C. | |
dc.contributor.author | DuBose, Stephanie N. | |
dc.contributor.author | Agarwal, Shivani | |
dc.contributor.author | Lyons, Sarah K. | |
dc.contributor.author | Peters, Anne L. | |
dc.contributor.author | Uwaifo, Gabriel I. | |
dc.contributor.author | DiMeglio, Linda A. | |
dc.contributor.author | Sherr, Jennifer L. | |
dc.contributor.author | Polsky, Sarit | |
dc.contributor.department | Pediatrics, School of Medicine | |
dc.date.accessioned | 2024-04-23T11:57:40Z | |
dc.date.available | 2024-04-23T11:57:40Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Objectives: To examine changes in device use and glycemic outcomes for pregnant women from the T1D Exchange Clinic Registry between the years 2010-2013 and 2016-2018. Methods: Participant-reported device use and glycemic outcomes were compared for women aged 16-40 years who were pregnant at the time of survey completion, comparing 2010-2013 (cohort 1) and 2016-2018 (cohort 2). Hemoglobin A1c results within 30 days prior to survey completion were obtained from medical records. Results: There were 208 pregnant women out of 5,236 eligible participants completing the questionnaire in cohort 1 and 47 pregnant women out of 2,818 eligible participants completing the questionaire in cohort 2. Continuous glucose monitor (CGM) use while pregnant trended upward among cohort 2 (70% vs 37%, P = .02), while reported continuous subcutaneous insulin infusion (CSII) use while pregnant declined (76% vs 64%, P = .04). HbA1c levels trended downward (6.8% cohort 1 vs 6.5% cohort 2, P = .07). Conclusions: Self-reported CGM use while pregnant increased over the studied intervals whereas CSII use decreased. Additional evaluation of device use and the potential benefits for T1D pregnancies is needed. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Levy CJ, Foster NC, DuBose SN, et al. Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange. J Diabetes Sci Technol. 2021;15(6):1297-1302. doi:10.1177/1932296820972123 | |
dc.identifier.uri | https://hdl.handle.net/1805/40141 | |
dc.language.iso | en_US | |
dc.publisher | Sage | |
dc.relation.isversionof | 10.1177/1932296820972123 | |
dc.relation.journal | Journal of Diabetes Science and Technology | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Continuous glucose monitor | |
dc.subject | Female | |
dc.subject | Pregnancy | |
dc.subject | Type 1 diabetes | |
dc.title | Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange | |
dc.type | Article | |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655289/ |